AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
This Quarter Return
-10.76%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$1.09B
AUM Growth
–
Cap. Flow
+$1.09B
Cap. Flow %
100%
Top 10 Hldgs %
95.05%
Holding
16
New
16
Increased
–
Reduced
–
Closed
–

Top Buys

1
KYMR icon
Kymera Therapeutics
KYMR
$437M
2
DAWN icon
Day One Biopharmaceuticals
DAWN
$138M
3
DYN icon
Dyne Therapeutics
DYN
$106M
4
REPL icon
Replimune Group
REPL
$87M
5
IMA
ImageneBio, Inc. Common Stock
IMA
$62.9M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KYMR icon
1
Kymera Therapeutics
KYMR
$2.95B
$437M 40.09%
+6,875,698
New +$437M
DAWN icon
2
Day One Biopharmaceuticals
DAWN
$769M
$138M 12.69%
+8,201,638
New +$138M
DYN icon
3
Dyne Therapeutics
DYN
$1.92B
$106M 9.76%
+8,934,902
New +$106M
REPL icon
4
Replimune Group
REPL
$422M
$87M 7.99%
+3,209,627
New +$87M
IMA
5
ImageneBio, Inc. Common Stock
IMA
$150M
$62.9M 5.78%
+5,018,178
New +$62.9M
GBIO icon
6
Generation Bio
GBIO
$40.4M
$58.6M 5.38%
+8,278,876
New +$58.6M
AKRO icon
7
Akero Therapeutics
AKRO
$3.74B
$47.2M 4.34%
+2,232,251
New +$47.2M
XLO icon
8
Xilio Therapeutics
XLO
$36.3M
$44.2M 4.06%
+2,759,344
New +$44.2M
JBIO
9
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$36.6M 3.36%
+3,103,879
New +$36.6M
TECX
10
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$17.4M 1.6%
+4,520,863
New +$17.4M
SPRO icon
11
Spero Therapeutics
SPRO
$116M
$16.5M 1.52%
+1,031,160
New +$16.5M
DNTH icon
12
Dianthus Therapeutics
DNTH
$759M
$15.4M 1.41%
+3,476,536
New +$15.4M
IRON icon
13
Disc Medicine
IRON
$2.07B
$15.3M 1.4%
+5,254,365
New +$15.3M
FSTX
14
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$3.01M 0.28%
+599,524
New +$3.01M
COGT icon
15
Cogent Biosciences
COGT
$1.69B
$1.91M 0.18%
+222,976
New +$1.91M
VRDN icon
16
Viridian Therapeutics
VRDN
$1.5B
$1.78M 0.16%
+90,072
New +$1.78M